The world has now reached a difficult situation with the outbreak of SARS-CoV-2, where access to tools in the detection of the virus is hampering the global response in isolating individuals from the greater population.
We continually hear about the need to flatten the infection curve to avoid a serious burden to our already stretched medical systems. But this can only happen if we have an effective surveillance system in place that is rapid and mobile.
Current testing of SARS-CoV-2 is centralized to a number of hospitals and private labs. Many of these tests are taking days to complete and individuals outside of major cities may not have access to the testing. The outcome of these delays is the potential for the virus to spread further in the community. Mic provides the capability to drastically reduce the time to receive a diagnosis from days to hours through decentralized testing.
Mic is compact, robust and ready to go out of the box making it the obvious choice for deployment in the field. Mic can be powered by battery and inverter systems, providing qPCR analysis capabilities in crisis centres or airports through to the most remote regions of the world. Combined with powerful yet simple to use software, the system can easily be used by most health care professionals, allowing access to testing anywhere and at any time. Mic has proven its ability to perform in mobile laboratories in Africa, on ships in the Atlantic Ocean and in outback Australia.
We have partnered with a number of diagnostic companies who have seen the benefits Mic provides to rapid and deployable diagnostics. It’s with the help of these partners that we can offer a reliable platform to help in the fight against COVID-19.
You can read more about the concept of decentralized testing and its benefits in epidemiological surveillance of outbreaks in this article.
Bio Molecular Systems is dedicated to making diagnostics easier, faster and more accessible for all.